603538 美诺华
已收盘 02-03 15:00:00
资讯
新帖
简况
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案获通过，2月2日股价下跌4.64%
证券之星 · 02-02 22:26
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案获通过，2月2日股价下跌4.64%
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件提示性公告，1月30日股价上涨0.09%
证券之星 · 01-30
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件提示性公告，1月30日股价上涨0.09%
美诺华：预计2025年全年扣非后净利润盈利8000万元至9500万元
证券之星 · 01-26
美诺华：预计2025年全年扣非后净利润盈利8000万元至9500万元
每周股票复盘：美诺华（603538）子公司获高新认证
证券之星 · 01-25
每周股票复盘：美诺华（603538）子公司获高新认证
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案，1月23日股价上涨6.83%
证券之星 · 01-23
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案，1月23日股价上涨6.83%
美诺华（603538）披露子公司通过高新技术企业重新认定，1月22日股价上涨0.53%
证券之星 · 01-22
美诺华（603538）披露子公司通过高新技术企业重新认定，1月22日股价上涨0.53%
美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，1月20日股价上涨0.29%
证券之星 · 01-20
美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，1月20日股价上涨0.29%
每周股票复盘：美诺华（603538）利奥西呱片获批丰富制剂管线
证券之星 · 01-18
每周股票复盘：美诺华（603538）利奥西呱片获批丰富制剂管线
美诺华（603538）披露拟向下修正“美诺转债”转股价格议案，1月16日股价下跌0.72%
证券之星 · 01-16
美诺华（603538）披露拟向下修正“美诺转债”转股价格议案，1月16日股价下跌0.72%
美诺华(603538.SH)子公司获得利奥西呱片药品注册证书
智通财经 · 01-12
美诺华(603538.SH)子公司获得利奥西呱片药品注册证书
每周股票复盘：美诺华（603538）美诺转债付息在即且转股价格或迎修正
证券之星 · 01-11
每周股票复盘：美诺华（603538）美诺转债付息在即且转股价格或迎修正
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，1月9日股价上涨0.57%
证券之星 · 01-09
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，1月9日股价上涨0.57%
美诺华（603538）披露“美诺转债”2026年付息公告，1月7日股价上涨0.89%
证券之星 · 01-07
美诺华（603538）披露“美诺转债”2026年付息公告，1月7日股价上涨0.89%
1月5日美诺华涨5.15%，新华策略精选股票A基金重仓该股
证券之星 · 01-05
1月5日美诺华涨5.15%，新华策略精选股票A基金重仓该股
每周股票复盘：美诺华（603538）使用1000万闲置募资购大额存单
证券之星 · 01-02
每周股票复盘：美诺华（603538）使用1000万闲置募资购大额存单
美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，12月30日股价上涨0.1%
证券之星 · 2025-12-30
美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，12月30日股价上涨0.1%
每周股票复盘：美诺华（603538）决定不向下修正转股价格
证券之星 · 2025-12-28
每周股票复盘：美诺华（603538）决定不向下修正转股价格
美诺华：第五届董事会第二十二次会议决议
证券日报 · 2025-12-24
美诺华：第五届董事会第二十二次会议决议
美诺华(603538.SH)子公司阿托伐他汀钙原料药通过CDE技术审评
智通财经 · 2025-12-18
美诺华(603538.SH)子公司阿托伐他汀钙原料药通过CDE技术审评
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，12月17日股价上涨0.05%
证券之星 · 2025-12-17
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，12月17日股价上涨0.05%
加载更多
公司概况
公司名称：
宁波美诺华药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-07
主营业务：
宁波美诺华药业股份有限公司的主营业务是特色原料药（包括中间体，下同）和制剂研发、生产与销售。公司的主要产品是缬沙坦、氯沙坦、培哚普利叔丁胺片、瑞舒伐他汀钙、阿托伐他汀钙、普瑞巴林、阿哌沙班片、异烟肼片。
发行价格：
14.03
{"stockData":{"symbol":"603538","market":"SH","secType":"STK","nameCN":"美诺华","latestPrice":20.68,"timestamp":1770102000000,"preClose":20.33,"halted":0,"volume":4118129,"delay":0,"changeRate":0.0172,"floatShares":216000000,"shares":221000000,"eps":0.4509,"marketStatus":"已收盘","change":0.35,"latestTime":"02-03 15:00:00","open":20.51,"high":20.69,"low":20.21,"amount":84336500,"amplitude":0.0236,"askPrice":20.68,"askSize":55,"bidPrice":20.67,"bidSize":122,"shortable":0,"etf":0,"ttmEps":0.4509,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770168600000},"marketStatusCode":5,"adr":0,"adjPreClose":20.33,"symbolType":"stock","openAndCloseTimeList":[[1770082200000,1770089400000],[1770094800000,1770102000000]],"highLimit":22.36,"lowLimit":18.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":220630759,"isCdr":false,"pbRate":2.03,"roa":"--","peRate":45.863828,"roe":"4.26%","epsLYR":0.31,"committee":-0.016827,"marketValue":4563000000,"turnoverRate":0.019,"status":0,"floatMarketCap":4471000000},"requestUrl":"/m/hq/s/603538","defaultTab":"news","newsList":[{"id":"2608671438","title":"美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案获通过，2月2日股价下跌4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608671438","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608671438?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:26","pubTimestamp":1770042379,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，美诺华报收于20.33元，较前一交易日下跌4.64%，最新总市值为44.85亿元。该股当日开盘21.21元，最高21.44元，最低20.25元，成交额达1.23亿元，换手率为2.75%。近日，宁波美诺华药业股份有限公司召开2026年第一次临时股东会，审议通过《关于向下修正“美诺转债”转股价格的议案》。表决结果显示，同意股份占出席会议股东有效表决权的93.3171%，反对占6.5554%，弃权占0.1275%。中小投资者中同意占20.4636%，反对占78.0194%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2607041750","title":"美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件提示性公告，1月30日股价上涨0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607041750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607041750?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:39","pubTimestamp":1769783956,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，美诺华报收于21.32元，较前一交易日上涨0.09%，最新总市值为47.04亿元。该股当日开盘21.42元，最高21.66元，最低21.0元，成交额达1.29亿元，换手率为2.79%。近日，宁波美诺华药业股份有限公司发布《关于“美诺转债”预计满足转股价格向下修正条件的提示性公告》。公司董事会将在触发条件当日审议是否修正转股价格，并及时履行信息披露义务。最终是否修正转股价格将以股东大会决议为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2606219460","title":"美诺华：预计2025年全年扣非后净利润盈利8000万元至9500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606219460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606219460?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:33","pubTimestamp":1769423597,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华发布业绩预告，预计2025年全年扣非后净利润盈利8000万元至9500万元。美诺华2025年三季报显示，前三季度公司主营收入11.17亿元，同比上升17.67%；归母净利润9592.54万元，同比上升51.66%；扣非净利润8635.96万元，同比上升64.66%；其中2025年第三季度，公司单季度主营收入4.39亿元，同比上升28.8%；单季度归母净利润4687.02万元，同比上升5.78%；单季度扣非净利润4960.71万元，同比上升51.29%；负债率49.05%，投资收益893.38万元，财务费用2800.1万元，毛利率33.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600025787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"gpt_icon":0},{"id":"2606223418","title":"每周股票复盘：美诺华（603538）子公司获高新认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2606223418","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606223418?lang=zh_cn&edition=full","pubTime":"2026-01-25 01:45","pubTimestamp":1769276716,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，美诺华报收于22.2元，较上周的20.69元上涨7.3%。本周，美诺华1月23日盘中最高价报22.38元。本周关注点公司公告汇总：宣城美诺华、创新研究院及美诺华天康通过高新技术企业重新认定，自2025年起三年内享受15%企业所得税优惠。宁波美诺华药业股份有限公司控股子公司宣城美诺华、全资子公司创新研究院及美诺华天康近日收到高新技术企业证书，均为原证书有效期满后的重新认定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2605405411","title":"美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案，1月23日股价上涨6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605405411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605405411?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:20","pubTimestamp":1769178027,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，美诺华报收于22.2元，较前一交易日上涨6.83%，最新总市值为48.98亿元。近日，宁波美诺华药业股份有限公司发布《2026年第一次临时股东会会议资料》，公告拟于2026年2月2日召开第一次临时股东会，审议关于向下修正“美诺转债”转股价格的议案。董事会提议向下修正转股价格，并授权董事会确定修正后的转股价格及生效日期等相关事项。该议案需经股东大会表决通过，且持有“美诺转债”的股东应回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2605510464","title":"美诺华（603538）披露子公司通过高新技术企业重新认定，1月22日股价上涨0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605510464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605510464?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:40","pubTimestamp":1769074842,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，美诺华报收于20.78元，较前一交易日上涨0.53%，最新总市值为45.85亿元。该股当日开盘20.68元，最高20.82元，最低20.64元，成交额达6983.26万元，换手率为1.56%。公司近日发布公告称，其控股子公司宣城美诺华、全资子公司创新研究院及美诺华天康已收到高新技术企业证书，均为原证书有效期满后的重新认定。根据相关规定，上述三家公司自2025年起连续三年可享受高新技术企业所得税优惠政策，按15%的税率缴纳企业所得税。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2604114850","title":"美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，1月20日股价上涨0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604114850","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604114850?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:39","pubTimestamp":1768919952,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，美诺华报收于20.62元，较前一交易日上涨0.29%，最新总市值为45.49亿元。该股当日开盘20.68元，最高20.9元，最低20.47元，成交额达9040.64万元，换手率为2.02%。公司近日发布公告称，宁波美诺华药业股份有限公司于2026年1月20日使用闲置可转债募集资金1,000万元购买招商银行单位大额存单2025年第5855期，产品期限3年，年化收益率1.75%，为固定利率型存款产品，允许提前转让。公司已对相关风险进行评估并制定控制措施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2604306923","title":"每周股票复盘：美诺华（603538）利奥西呱片获批丰富制剂管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2604306923","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604306923?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:33","pubTimestamp":1768674787,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，美诺华报收于20.69元，较上周的21.1元下跌1.94%。公司公告汇总：预计2026年与科尔康美诺华日常关联交易不超6,000万元，用于制剂生产及原料药销售等。此次获批有助于增强公司产品竞争力并丰富制剂产品线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2603991021","title":"美诺华（603538）披露拟向下修正“美诺转债”转股价格议案，1月16日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603991021?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:21","pubTimestamp":1768573276,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，美诺华报收于20.69元，较前一交易日下跌0.72%，最新总市值为45.65亿元。该股当日开盘20.89元，最高20.97元，最低20.48元，成交额达1.02亿元，换手率为2.28%。公司近日发布公告称，将于2026年2月2日召开2026年第一次临时股东会，会议将审议《关于向下修正“美诺转债”转股价格的议案》。该议案属于特别决议议案，需对中小投资者单独计票，关联股东需回避表决。股权登记日为2026年1月26日，股东可于2026年1月28日办理现场登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600041045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2602590049","title":"美诺华(603538.SH)子公司获得利奥西呱片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2602590049","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602590049?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:21","pubTimestamp":1768209673,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美诺华(603538.SH)发布公告，公司全资子公司宁波美诺华天康药业有限公司(简称“美诺华天康”)于近日收到国家药品监督管理局核准签发的利奥西呱片《药品注册证书》。药品适应症：适用于慢性血栓栓塞性肺动脉高压(CTEPH);动脉性肺动脉高压(PAH)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美诺华(603538.SH)子公司获得利奥西呱片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2602271535","title":"每周股票复盘：美诺华（603538）美诺转债付息在即且转股价格或迎修正","url":"https://stock-news.laohu8.com/highlight/detail?id=2602271535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602271535?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:23","pubTimestamp":1768072987,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，美诺华报收于21.1元，较上周的19.24元上涨9.67%。公司公告汇总：截至2025年12月31日，累计43,609,000元“美诺转债”完成转股，转股数量为1,178,999股。公告同时列示了转股价格历次调整情况。宁波美诺华药业股份有限公司关于“美诺转债”预计满足转股价格向下修正条件的提示性公告表示，自2025年12月25日起至2026年1月9日，已有连续十个交易日公司股票收盘价低于当期转股价格25.68元/股的90%，即低于23.11元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2602374981","title":"美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，1月9日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602374981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602374981?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:32","pubTimestamp":1767969135,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，美诺华报收于21.1元，较前一交易日上涨0.57%，最新总市值为46.55亿元。该股当日开盘20.97元，最高21.14元，最低20.68元，成交额达1.49亿元，换手率为3.31%。公司近日发布公告，提示“美诺转债”可能触发转股价格向下修正条件。若未来二十个交易日内有五个交易日收盘价低于23.11元/股，将可能触发向下修正条款。公司将在符合条件后召开董事会审议是否修正转股价格，并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2601801788","title":"美诺华（603538）披露“美诺转债”2026年付息公告，1月7日股价上涨0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801788","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801788?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:43","pubTimestamp":1767796989,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，美诺华报收于20.48元，较前一交易日上涨0.89%，最新总市值为45.19亿元。该股当日开盘20.29元，最高20.75元，最低20.26元，成交额达1.29亿元，换手率为2.91%。公司近日发布公告称，宁波美诺华药业股份有限公司于2021年1月14日发行的可转换公司债券将于2026年1月14日支付第五年利息，计息期间为2025年1月14日至2026年1月13日，票面利率1.8%，每张兑息1.80元（含税）。兑息对象为登记在册的全体可转债持有人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2601300518","title":"1月5日美诺华涨5.15%，新华策略精选股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601300518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601300518?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:33","pubTimestamp":1767598427,"startTime":"0","endTime":"0","summary":"证券之星消息，1月5日美诺华涨5.15%，收盘报20.23元，换手率4.22%，成交量9.12万手，成交额1.83亿元。重仓美诺华的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家；过去90天内机构目标均价为26.04。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为新华基金的新华策略精选股票A。该公募基金现任基金经理为赵强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2600035086","title":"每周股票复盘：美诺华（603538）使用1000万闲置募资购大额存单","url":"https://stock-news.laohu8.com/highlight/detail?id=2600035086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600035086?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:15","pubTimestamp":1767291312,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，美诺华报收于19.69元，较上周的19.9元下跌1.06%。本周，美诺华12月22日盘中最高价报19.96元。公司公告汇总宁波美诺华药业股份有限公司于2025年12月30日使用闲置可转债募集资金1,000万元购买招商银行单位大额存单2025年第5834期，产品期限3年，年化收益率1.75%，为固定利率型存款产品，允许提前转让。本次行权后总股本由220,630,566股增至220,630,759股，实际控制人未发生变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2595187877","title":"美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，12月30日股价上涨0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595187877","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595187877?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:33","pubTimestamp":1767105195,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，美诺华报收于19.48元，较前一交易日上涨0.1%，最新总市值为42.98亿元。该股当日开盘19.37元，最高19.52元，最低19.26元，成交额达6283.99万元，换手率为1.5%。公司近日发布公告称，宁波美诺华药业股份有限公司于2025年12月30日使用闲置可转债募集资金1,000万元购买招商银行单位大额存单2025年第5834期，产品期限3年，年化收益率1.75%，为固定利率型存款产品，允许提前转让。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2594420592","title":"每周股票复盘：美诺华（603538）决定不向下修正转股价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2594420592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594420592?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:34","pubTimestamp":1766867651,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，美诺华报收于19.69元，较上周的19.9元下跌1.06%。本周，美诺华12月22日盘中最高价报19.96元。本周关注点公司公告汇总：美诺华决定不向下修正“美诺转债”转股价格。公司公告汇总宁波美诺华药业股份有限公司于2025年12月24日召开第五届董事会第二十二次会议，审议通过《关于不向下修正可转换公司债券转股价格的议案》，表决结果为同意5票，反对0票，弃权0票，议案获全票通过。公司董事会决定本次不向下修正转股价格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2593744254","title":"美诺华：第五届董事会第二十二次会议决议","url":"https://stock-news.laohu8.com/highlight/detail?id=2593744254","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593744254?lang=zh_cn&edition=full","pubTime":"2025-12-24 19:38","pubTimestamp":1766576280,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月24日，美诺华（维权）发布公告称，公司第五届董事会第二十二次会议审议通过《关于不向下修正可转换公司债券转股价格的议案》。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxcti4388392.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxcti4388392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2592973572","title":"美诺华(603538.SH)子公司阿托伐他汀钙原料药通过CDE技术审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2592973572","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592973572?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:56","pubTimestamp":1766044573,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美诺华(603538.SH)发布公告，近日，公司控股子公司宣城美诺华药业有限公司(简称“宣城美诺华”)收到国家药品监督管理局核准签发的阿托伐他汀钙原料药《化学原料药上市申请批准通知书》。宣城美诺华的阿托伐他汀钙原料药通过CDE技术审评，证明该原料药已符合国家相关药品审评技术标准，可销售至国内市场，将进一步丰富子公司的产品线，有助于拓展公司业务领域，有利于进一步扩展公司原料药制剂一体化生产范围，增强公司一体化生产的优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1223083913.SGD","CDE","603538","BK0239","LU1223082519.USD","LU1223082196.USD","BK4017"],"gpt_icon":0},{"id":"2592915851","title":"美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，12月17日股价上涨0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592915851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592915851?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:10","pubTimestamp":1765980647,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，美诺华报收于19.4元，较前一交易日上涨0.05%，最新总市值为42.8亿元。该股当日开盘19.39元，最高19.46元，最低18.97元，成交额达7173.35万元，换手率为1.72%。公司近日发布公告，提示“美诺转债”可能触发转股价格向下修正条件。截至2025年12月17日，已有连续十个交易日公司股票收盘价低于当期转股价格25.68元/股的90%，即23.11元/股。公司将在触发条件当日召开董事会审议是否修正转股价格，并及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700039288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770166106656,"stockEarnings":[{"period":"1week","weight":-0.0706},{"period":"1month","weight":0.0748},{"period":"3month","weight":-0.0922},{"period":"6month","weight":-0.1274},{"period":"1year","weight":0.6544},{"period":"ytd","weight":0.0748}],"compareEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":0.0249},{"period":"3month","weight":0.0248},{"period":"6month","weight":0.1176},{"period":"1year","weight":0.2514},{"period":"ytd","weight":0.0249}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波美诺华药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34704人(较上一季度增加7.22%)","perCapita":"6229股","listingDate":"2017-04-07","address":"浙江省宁波市鄞州区高新区扬帆路999弄1号1406室","registeredCapital":"22063万元","survey":" 宁波美诺华药业股份有限公司的主营业务是特色原料药（包括中间体，下同）和制剂研发、生产与销售。公司的主要产品是缬沙坦、氯沙坦、培哚普利叔丁胺片、瑞舒伐他汀钙、阿托伐他汀钙、普瑞巴林、阿哌沙班片、异烟肼片。","listedPrice":14.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美诺华,603538,美诺华股票,美诺华股票老虎,美诺华股票老虎国际,美诺华行情,美诺华股票行情,美诺华股价,美诺华股市,美诺华股票价格,美诺华股票交易,美诺华股票购买,美诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}